Jordan Walter majored in Neuroscience and Latin American Studies and minored in Chemistry as an undergraduate at Wesleyan University. During her time at Wesleyan, she helped conduct research on [...]
Anders Baum is a Clinical Research Coordinator in the Frontotemporal Disorders (FTD) Unit. He has a bachelor’s degree in biology from Hamilton College and previously interned at the Joslin [...]
Matthew Walsh is an Adult-Geriatric Acute Care Certified Nurse Practitioner. He is MA native who grew up on Cape Cod and now living in Wakefield, MA. He earned both his BSN and MSN from Duke [...]
Thiago Paranhos earned his MD from the Federal University of Rio de Janeiro, Brazil (2022). During his medical training, he had the opportunity to shadow the clinical and research activities of a [...]
Nikita Jain, MD is the Sydney Baer Clinical Research Fellow in Behavioral Neurology and Neuropsychiatry at MGH. Dr. Jain earned her medical degree at Wake Forest School of Medicine, where she [...]
Today the U.S. Food and Drug Administration approved donanemab for the treatment of people living with early symptomatic Alzheimer’s disease, which includes mild cognitive impairment and the mild [...]
Today the first MGH patients received lecanemab infusions for early-stage Alzheimer’s disease. We have been working diligently with our colleagues at the Brigham to develop uniform procedures for [...]